Edition:
India

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.98USD
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
$2.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,198
52-wk High
$7.15
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
FY 2015 Dec '15 46.37 -13.349
Sep '15 48.62 -1.762
Jun '15 46.98 -6.152
Mar '15 33.89 -6.157
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.15 32.96
P/E High - Last 5 Yrs. -- 40.78 45.57
P/E Low - Last 5 Yrs. -- 23.79 24.35
Beta 1.69 0.90 0.89
Price to Sales (TTM) 0.26 3.94 5.25
Price to Book (MRQ) -- 4.83 5.40
Price to Tangible Book (MRQ) -- 5.47 6.73
Price to Cash Flow (TTM) -- 23.18 23.58
% Owned Institutions 21.30 0.77 1.29

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 1.54 1.49
Dividend 5 Year Growth Rate -- 4.38 5.23
Payout Ratio(TTM) -- 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.75 5.41
Sales - 5 Yr. Growth Rate 18.37 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 10.04 10.96
Capital Spending - 5 Yr. Growth Rate 41.15 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.12 2.20
Current Ratio (MRQ) 0.75 2.91 3.00
LT Debt to Equity (MRQ) -- 8.63 10.82
Total Debt to Equity (MRQ) -- 12.47 14.95
Interest Coverage (TTM) -9.29 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 54.92 54.68
Gross Margin - 5 Yr. Avg. 64.57 52.01 52.15
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.41 15.51
Operating Margin (TTM) -93.55 14.62 9.27
Operating Margin - 5 Yr. Avg. -56.18 14.52 11.18
Pre-Tax Margin (TTM) -120.18 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.85 11.61
Net Profit Margin (TTM) -120.56 11.35 6.37
Net Profit Margin - 5 Yr. Avg. -65.04 11.16 7.88
Effective Tax Rate (TTM) -- 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 967,481,775 876,721,579
Net Income/Employee (TTM) -884,286 113,847,942 103,151,091
Receivable Turnover (TTM) 2.90 5.62 5.78
Inventory Turnover (TTM) 4.45 2.58 3.35
Asset Turnover (TTM) 0.42 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.53 11.10
Return on Assets - 5 Yr. Avg. -23.23 13.15 12.57
Return on Investment (TTM) -74.47 14.99 14.58
Return on Investment - 5 Yr. Avg. -31.36 17.20 16.46
Return on Equity (TTM) -- 16.33 16.09
Return on Equity - 5 Yr. Avg. -138.91 18.16 17.62
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.62%
# of Holders: 43
Total Shares Held: 2,493,876
3 Mo. Net Change: 266,433
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 15
# Reduced Positions: 10
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.